Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Thromboxane B2 Assay Validation with Aspirin
NCT03424408Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Mar 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin in atherothrombosis, sponsored by Hamilton Health Sciences. Primary endpoint: Serum Thromboxane B2 Level at 5 days. Started Mar 2018; status: completed.
02
Drugs
aspirin
03
Conditions
atherothrombosis
Beyond the preview
Go deeper on NCT03424408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03424408.